Of note, miR-29c is itself a post-transcriptional regulator of DNMT3b, and others have shown that DNMT3b is overexpressed in breast cancer cell lines with a hypermethylator phenotype [12, 38]. Here, DNMT3B is linked to breast carcinoma.